Gemtuzumab and acute respiratory distress syndrome Patient Reports February 13, 2012



Gemtuzumab Side Effects Report #5243941-8
Gemtuzumab side effect was reported by a Pharmacist from UNITED STATES on Feb 20, 2007. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, blood pressure decreased, chills, pain What is  pain. Gemtuzumab dosage: unknown. During the same period patient was treated with MYLOTARG. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5217741-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from ITALY on Jan 15, 2007. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome. Gemtuzumab dosage: unknown. Patient recovered.

Gemtuzumab Side Effects Report #4867037-X
Gemtuzumab side effect was reported by a Health Professional from FRANCE on Mar 10, 2002. Female patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anxiety What is  anxiety, constipation What is  constipation, eye haemorrhage, flatulence, oliguria. Gemtuzumab dosage: 9 MG/M (2) INTRAVENOUS. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #4869652-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Dec 20, 2005. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome. Gemtuzumab dosage: unknown. Patient died.


Gemtuzumab Side Effects Report #5598874-4
Gemtuzumab side effect was reported by a Physician from CANADA on Jan 15, 2008. Female patient, 58 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome. Gemtuzumab dosage: 12 MG. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5611055-0
Gemtuzumab side effect was reported by a Physician from CANADA on Jan 30, 2008. Female patient, 58 years of age, weighting 198.4 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, septic shock, tumour lysis syndrome. Gemtuzumab dosage: 12 MG. During the same period patient was treated with CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient died on 01/19/2008.

Gemtuzumab Side Effects Report #5259681-5
Gemtuzumab side effect was reported by a Physician from FRANCE on Mar 05, 2007. Male patient, weighting 180.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, lung infection pseudomonal, tuberculosis What is  tuberculosis. Gemtuzumab dosage: SINGLE DOSE: 12.0 MG; CUMULATIVE DOSE: 24 MG. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5277131-X
Gemtuzumab side effect was reported by a Physician from BELGIUM on Mar 15, 2007. Male patient, weighting 186.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, condition aggravated, disseminated intravascular coagulation, hepatocellular damage, multi-organ failure. Gemtuzumab dosage: unknown. During the same period patient was treated with MERONEM, TARGOCID. Patient died on 03/23/2004.

Gemtuzumab Side Effects Report #5303395-X
Gemtuzumab side effect was reported by a Physician from GERMANY on Apr 16, 2007. Male patient, weighting 146.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, subdural haematoma. Gemtuzumab dosage: 10.98 MG FOR A TOTAL DOSE OF 21.960. Patient was hospitalized. Patient died on 09/04/2006.


Gemtuzumab Side Effects Report #5380944-7
Gemtuzumab side effect was reported by a Physician from ITALY on July 04, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, multi-organ failure, septic shock. Gemtuzumab dosage: unknown. Patient died on 06/25/2007.

Gemtuzumab Side Effects Report #5523824-6
Gemtuzumab side effect was reported by a Physician from FRANCE on Nov 20, 2007. Male patient, weighting 180.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, lung infection pseudomonal, pyrexia, tuberculosis What is  tuberculosis. Gemtuzumab dosage: SINGLE DOSE: 12.0 MG; CUMULATIVE DOSE: 24 MG. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5573686-6
Gemtuzumab side effect was reported by a Physician from ITALY on Dec 21, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, septic shock. Gemtuzumab dosage: unknown. Patient died on 06/25/2007.

Gemtuzumab Side Effects Report #5591881-7
Gemtuzumab side effect was reported by a Physician from ITALY on Jan 04, 2008. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, multi-organ failure, septic shock, staphylococcal infection What is  staphylococcal infection. Gemtuzumab dosage: unknown. Patient died on 06/24/2007.

Gemtuzumab Side Effects Report #5595061-0
Gemtuzumab side effect was reported by a Physician from FRANCE on Jan 10, 2008. Male patient, weighting 180.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, lung infection pseudomonal, pyrexia, tuberculosis What is  tuberculosis. Gemtuzumab dosage: SINGLE DOSE: 12.0 MG; CUMULATIVE DOSE: 24 MG. Patient was hospitalized. Patient recovered.


Gemtuzumab Side Effects Report #5644254-2
Gemtuzumab side effect was reported by a Physician from GERMANY on Feb 25, 2008. Female patient, weighting 146.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, subdural haematoma. Gemtuzumab dosage: 10.98 MG FOR A TOTAL DOSE OF 21.960. Patient was hospitalized. Patient died on 09/04/2006.

Gemtuzumab Side Effects Report #5853047-2
Gemtuzumab side effect was reported by a Physician from FRANCE on Aug 19, 2008. Female patient, weighting 105.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome. Gemtuzumab dosage: unknown. During the same period patient was treated with CASPOFUNGIN ACETATE, MITOXANTRONE, TARGOCID, ETOPOSIDE, IMIPENEM. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5870782-0
Gemtuzumab side effect was reported by a Physician from FRANCE on Sept 01, 2008. Female patient, weighting 105.8 lb, was diagnosed with acute myeloid leukaemia, febrile neutropenia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, lung disorder. Gemtuzumab dosage: unknown. During the same period patient was treated with BACTRIM, MITOXANTRONE, TARGOCID, CASPOFUNGIN ACETATE, ETOPOSIDE, IMIPENEM. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5905345-1
Gemtuzumab side effect was reported by a Physician from FRANCE on Sept 29, 2008. Female patient, weighting 105.8 lb, was diagnosed with acute myeloid leukaemia, febrile neutropenia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, lung disorder. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, BACTRIM, MITOXANTRONE, TARGOCID, CASPOFUNGIN ACETATE, ETOPOSIDE, IMIPENEM. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #6086704-6
Gemtuzumab side effect was reported by a Physician from FRANCE on Feb 18, 2009. Female patient, weighting 105.8 lb, was diagnosed with acute myeloid leukaemia, febrile neutropenia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, lung disorder. Gemtuzumab dosage: unknown. During the same period patient was treated with BACTRIM, MITOXANTRONE, TARGOCID, CASPOFUNGIN ACETATE, ETOPOSIDE, IMIPENEM. Patient was hospitalized. Patient recovered.


Gemtuzumab Side Effects Report #6092725-X
Gemtuzumab side effect was reported by a Physician from FRANCE on Feb 23, 2009. Female patient, weighting 105.8 lb, was diagnosed with acute myeloid leukaemia, febrile neutropenia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, lung disorder. Gemtuzumab dosage: unknown. During the same period patient was treated with BACTRIM, MITOXANTRONE, TARGOCID, CASPOFUNGIN ACETATE, ETOPOSIDE, IMIPENEM. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4704478-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from on June 30, 2005. Female patient, weighting 121.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, chills, echocardiogram abnormal, ejection fraction decreased, haemodialysis, hypokalaemia, hypokinesia, lung disorder, neutropenia. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, ETOPOSIDE. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Gemtuzumab